Current Standard in Monitoring of Immunotherapy-Related Toxicity

被引:1
|
作者
Mathias, C. [1 ]
机构
[1] Nob, Med Oncol, Salvador, BA, Brazil
关键词
IPILIMUMAB;
D O I
10.1016/j.jtho.2017.09.184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
GR 02.04
引用
收藏
页码:S1658 / S1659
页数:2
相关论文
共 50 条
  • [32] Progress in the research of immunotherapy-related hyperprogression (Review)
    Qi, Ruizhe
    Yang, Lihui
    Zhao, Xinchao
    Huo, Liying
    Wang, Yaling
    Zhang, Peifang
    Chen, Xiaomei
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (01)
  • [33] Immunotherapy-Related Hematological Adverse Events: Incidence and Outcomes
    Grinsztejn, Eduarda
    Perez, Jaime A.
    DeSouza, Sherwin I.
    BLOOD, 2023, 142
  • [34] Xerostomia: an immunotherapy-related adverse effect in cancer patients
    Bustillos, Hannah
    Indorf, Amy
    Alwan, Laura
    Thompson, John
    Jung, Lindsey
    SUPPORTIVE CARE IN CANCER, 2022, 30 (02) : 1681 - 1687
  • [35] Development of an Oral Immunotherapy-Related Parental Burden Scale
    Maeta, Akihiro
    Takaoka, Yuri
    Hamada, Masaaki
    Nakano, Atsuko
    Sumimoto, Shinichi
    Anzai, Kaori
    Tanaka, Yukiko
    Morikawa, Satoru
    Kameda, Makoto
    Takahashi, Kyoko
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (12) : 1203 - 1215
  • [36] Germline variants associated with immunotherapy-related adverse events
    Groha, Stefan
    Abou Alaiwi, Sarah
    Xu, Wenxin
    Naranbhai, Vivek
    Nassar, Amin
    Bakouny, Ziad
    Adib, Elio
    Nuzzo, Pier
    Schmidt, Andrew
    Labaki, Chris
    El Zarif, Talal
    Ricciuti, Biagio
    Alessi, Joao Victor
    Braun, David
    Shukla, Sachet
    Keenan, Tanya
    Van Allen, Eliezer
    Awad, Mark
    Manos, Michael
    Rahma, Osama
    Zubiri, Leyre
    Villani, Alexandra-Chloe
    Hammer, Christian
    Khan, Zia
    Reynolds, Kerry
    Semenov, Yevgeniy
    Schrag, Deborah
    Kehl, Kenneth
    Freedman, Matthew
    Choueiri, Toni
    Gusev, Alexander
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 692 - 693
  • [37] Xerostomia: an immunotherapy-related adverse effect in cancer patients
    Hannah Bustillos
    Amy Indorf
    Laura Alwan
    John Thompson
    Lindsey Jung
    Supportive Care in Cancer, 2022, 30 : 1681 - 1687
  • [38] Management of Immunotherapy-Related Toxicities. Version 1.2019
    Thompson, John A.
    Schneider, Bryan J.
    Brahmer, Julie
    Andrews, Stephanie
    Armand, Philippe
    Bhatia, Shailender
    Budde, Lihua E.
    Costa, Luciano
    Davies, Marianne
    Dunnington, David
    Ernstoff, Marc S.
    Frigault, Matthew
    Hoffner, Brianna
    Hoimes, Christopher J.
    Lacouture, Mario
    Locke, Frederick
    Lunning, Matthew
    Mohindra, Nisha A.
    Naidoo, Jarushka
    Olszanski, Anthony J.
    Oluwole, Olalekan
    Patel, Sandip P.
    Reddy, Sunil
    Ryder, Mabel
    Santomasso, Bianca
    Shofer, Scott
    Sosman, Jeffrey A.
    Wahidi, Momen
    Wang, Yinghong
    Johnson-Chilla, Alyse
    Scavone, Jillian L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (03): : 255 - 288
  • [39] Lymphocytic colitis-like pattern of mucosal injury and the challenges in diagnosing cancer immunotherapy-related toxicity
    Grover, Shilpa
    Srivastava, Amitabh
    CANCER, 2019, 125 (11) : 1768 - 1770
  • [40] IMMUNOTHERAPY-RELATED NEPHRITIS IN A MELANOMA PATIENT: A CASE STUDY
    Dallen, R.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 29 - 29